Advertisement
Advertisement
ZLAB
Zai Lab Limited - ADR
20.59
USDSponsored
+0.26
+1.28%
May 15, 15:59 UTC -4
Closed
After-Market
20.56
-0.03
-0.15%
ZLAB Earnings Reports
Positive Surprise Ratio
ZLAB beat 14 of 19 last estimates.
74%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$107.88M
/-$0.05
Implied change from Q1 26 (Revenue/ EPS)
+8.30%
/--
Implied change from Q2 25 (Revenue/ EPS)
-1.91%
/+25.00%
Zai Lab Limited - ADR earnings per share and revenue
On May 07, 2026, ZLAB reported earnings of -0.05 USD per share (EPS) for Q1 26, missing the estimate of -0.04 USD, resulting in a -4.38% surprise. Revenue reached 99.61 million, compared to an expected 106.45 million, with a -6.42% difference. The market reacted with a -5.93% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.05 USD, with revenue projected to reach 107.88 million USD, implying an increase of 0.00% EPS, and increase of 8.30% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Celcuity Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$1.07
Actual
-$0.97
Surprise
+9.67%
Invivyd, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.13
Surprise
-73.80%
Autolus Therapeutics plc - ADR
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.26
Actual
-$0.27
Surprise
-2.94%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+217.65%
MiNK Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.78
Actual
-$0.56
Surprise
+27.43%
Elutia Inc. Class A Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
RenovoRx, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+1.96%
Dare Bioscience, Inc. Common Stock
Report Date
May 14, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.20
Surprise
+32.39%
Lantern Pharma Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+18.30%
BioCardia, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.21
Surprise
-24.78%
FAQ
What were Zai Lab Limited - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Zai Lab Limited - ADR reported EPS of -$0.05, missing estimates by -4.38%, and revenue of $99.61M, -6.42% below expectations.
How did the market react to Zai Lab Limited - ADR's Q1 2026 earnings?
The stock price moved down -5.93%, changed from $21.01 before the earnings release to $19.77 the day after.
When is Zai Lab Limited - ADR expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Zai Lab Limited - ADR's next earnings report?
Based on --
analysts, Zai Lab Limited - ADR is expected to report EPS of -$0.05 and revenue of $107.88M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement